Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04539 |
| Species: | Homo sapiens |
| Position : | chr11:5224750-5226210 |
| Year: | 2007 |
| Title: | Beta-globin intergenic transcription and histone acetylation dependent on an enhancer. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 17283048 |
| Tissue: | urinary bladder |
| Tissue Ontology ID: | UBERON:0001255 |
| Cell Source: | T24 |
| CVCL ID: | CVCL_0554 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| Low Throughput Method: | ChIP-RT-qPCR, RT-RT-qPCR, RNase protection assay, RNA FISH, DNA FISH |
| Target gene : | HBE1 |
| TF name : | NFE2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| NFE2 | Factors involved in megakaryocyte development and platelet production | reactome | 111 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02356 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02363 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02364 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02365 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_04366 | chr11:5225400-5225774 | bone marrow | malignant cell | NA |